Ian Frazer MD PhD

• Leading antiviral researcher & clinical immunologist
  
• Co-inventor and Principal Investigator for Gardisil, Merck's HPV vaccine
  
• Director Center for Cancer & Immunology Research

Ian Frazer was trained as a renal physician and clinical immunologist in Edinburgh, Scotland before emigrating in 1980 to Melbourne, Australia to pursue studies in viral immunology and autoimmunity at the Walter and Eliza Hall institute of Medical Research with Prof Ian Mackay. In 1985 his research base moved to the Princess Alexandra Hospital in Brisbane.

His current research interests include immunoregulation, and immunotherapeutic vaccines for Papillomavirus associated cancers. Dr Frazer holds research funding from several Australian and US funding bodies. He is a director of a biotechnology start up company, Coridon, with an interest in optimising and targeting polynucleotide vaccine protein expression.

He chairs the medical and scientific advisory committee of the Queensland Cancer Fund, and advises the WHO and the Bill and Melinda Gates Foundation on papillomavirus vaccines. Ian was recently made a Fellow of the Australian Academy of Science and was awarded a Eureka Prize in recognition of his development of the CSL/Merck HPV vaccine.

• Australian of the Year (2006)
• William B Coley Award for distinguished research in tumor immunology